
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Taxanes prodrug-based nanomedicines for cancer therapy
Linlin Sun, Pan Zhao, Menghan Chen, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 672-691
Closed Access | Times Cited: 30
Linlin Sun, Pan Zhao, Menghan Chen, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 672-691
Closed Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Doxorubicin prodrug-based nanomedicines for the treatment of cancer
Haibo Zhao, Jing Yu, Renshuai Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115612-115612
Closed Access | Times Cited: 51
Haibo Zhao, Jing Yu, Renshuai Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115612-115612
Closed Access | Times Cited: 51
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 15
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 15
Carbon-Spaced Tandem-Disulfide Bond Bridge Design Addresses Limitations of Homodimer Prodrug Nanoassemblies: Enhancing Both Stability and Activatability
Hao Zhang, Tian Liu, Yitong Sun, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 32, pp. 22675-22688
Closed Access | Times Cited: 9
Hao Zhang, Tian Liu, Yitong Sun, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 32, pp. 22675-22688
Closed Access | Times Cited: 9
Hybrid prodrug nanoassembly for hypoxia-triggered immunogenic chemotherapy and immune modulation
Beiyuan Zhang, Chao Qin, Xue Wang, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 221-235
Closed Access | Times Cited: 1
Beiyuan Zhang, Chao Qin, Xue Wang, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 221-235
Closed Access | Times Cited: 1
A Paclitaxel Prodrug with Copper Depletion for Combined Therapy toward Triple-Negative Breast Cancer
Dengyuan Hao, Qian Meng, Chaonan Li, et al.
ACS Nano (2023) Vol. 17, Iss. 13, pp. 12383-12393
Closed Access | Times Cited: 21
Dengyuan Hao, Qian Meng, Chaonan Li, et al.
ACS Nano (2023) Vol. 17, Iss. 13, pp. 12383-12393
Closed Access | Times Cited: 21
Camptothecin-based prodrug nanomedicines for cancer therapy
Renshuai Zhang, Jing Yu, Zhu Guo, et al.
Nanoscale (2023) Vol. 15, Iss. 44, pp. 17658-17697
Closed Access | Times Cited: 19
Renshuai Zhang, Jing Yu, Zhu Guo, et al.
Nanoscale (2023) Vol. 15, Iss. 44, pp. 17658-17697
Closed Access | Times Cited: 19
A computer-aided, heterodimer-based “triadic” carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency
Liyan Yang, Yingying Zhang, Yuxin Lai, et al.
Journal of Colloid and Interface Science (2024) Vol. 677, pp. 523-540
Closed Access | Times Cited: 7
Liyan Yang, Yingying Zhang, Yuxin Lai, et al.
Journal of Colloid and Interface Science (2024) Vol. 677, pp. 523-540
Closed Access | Times Cited: 7
Recent Advances in Engineering Prodrug-based Nanomedicines for Cancer Therapy
Linlin Shi, Shanshan Lin, Fengping Zhou, et al.
Materials Advances (2024) Vol. 5, Iss. 11, pp. 4634-4659
Open Access | Times Cited: 5
Linlin Shi, Shanshan Lin, Fengping Zhou, et al.
Materials Advances (2024) Vol. 5, Iss. 11, pp. 4634-4659
Open Access | Times Cited: 5
Advances in self-assembled nanotechnology in tumor therapy
Yanting Kuang, Zhaokai Li, Hang Chen, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 237, pp. 113838-113838
Closed Access | Times Cited: 4
Yanting Kuang, Zhaokai Li, Hang Chen, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 237, pp. 113838-113838
Closed Access | Times Cited: 4
Biomaterials-mediated biomineralization for tumor blockade therapy
Chao Sun, Shuqiang Li, Jianxun Ding
Nanomedicine (2025), pp. 1-9
Closed Access
Chao Sun, Shuqiang Li, Jianxun Ding
Nanomedicine (2025), pp. 1-9
Closed Access
Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives
X. Shi, Kai Tang, Quanbin Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
X. Shi, Kai Tang, Quanbin Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
A chemotherapy nano-booster unlocks wider therapeutic window for prostate cancer treatment
Rui Liao, Yuequan Wang, Ziqi Lin, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Rui Liao, Yuequan Wang, Ziqi Lin, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Anticancer therapy-induced peripheral neuropathy in solid tumors: diagnosis, mechanisms, and treatment strategies
Jiahong Jiang, Luna Jia Zhan, Bo Jiang, et al.
Cancer Letters (2025), pp. 217679-217679
Closed Access
Jiahong Jiang, Luna Jia Zhan, Bo Jiang, et al.
Cancer Letters (2025), pp. 217679-217679
Closed Access
Hypoxia-responsive core-cross-linked supramolecular nanoprodrug based on dendritic drug-drug conjugates for synergetic anticancer therapy
Yue Ding, Yu Xie, Li‐Min Zheng, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Yue Ding, Yu Xie, Li‐Min Zheng, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Stimuli-responsive heparin-drug conjugates co-assembled into stable nanomedicines for cancer therapy
Zaixiang Fang, Ling Lin, Zhiqian Li, et al.
Acta Biomaterialia (2023) Vol. 164, pp. 422-434
Closed Access | Times Cited: 10
Zaixiang Fang, Ling Lin, Zhiqian Li, et al.
Acta Biomaterialia (2023) Vol. 164, pp. 422-434
Closed Access | Times Cited: 10
Minor Changes in Response Modules Leading to a “U-Shaped” Conversion Rate of Docetaxel Prodrug Nanoassemblies
Wenxiao Li, Danping Wang, Haiyu Zhao, et al.
Nano Letters (2023) Vol. 24, Iss. 1, pp. 394-401
Closed Access | Times Cited: 9
Wenxiao Li, Danping Wang, Haiyu Zhao, et al.
Nano Letters (2023) Vol. 24, Iss. 1, pp. 394-401
Closed Access | Times Cited: 9
Prodrug-based nanomedicines for rheumatoid arthritis
Pei Li, Cong Wang, Hongjie Huo, et al.
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Pei Li, Cong Wang, Hongjie Huo, et al.
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Graphene oxide-templated biomineralization nanosystem enables multi-drug loading and controllable release
Zhechen Fan, Yishan Chen, Qian Li, et al.
Journal of Nanoparticle Research (2024) Vol. 26, Iss. 6
Closed Access | Times Cited: 2
Zhechen Fan, Yishan Chen, Qian Li, et al.
Journal of Nanoparticle Research (2024) Vol. 26, Iss. 6
Closed Access | Times Cited: 2
A co-delivery system based on chlorin e6-loaded ROS-sensitive polymeric prodrug with self-amplified drug release to enhance the efficacy of combination therapy for breast tumor cells
Cui Wang, Xiaoqing Yang, Haibao Qiu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 6
Cui Wang, Xiaoqing Yang, Haibao Qiu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 6
PEGylated Redox/pH Dual‐Responsive Dendritic Prodrugs Based on Boltorn® H40 for Tumor Triggered Paclitaxel Delivery
Elham Mohammadi, Seyed Jamal Tabatabaei Rezaei, Keivan Nedaei, et al.
ChemistrySelect (2023) Vol. 8, Iss. 4
Closed Access | Times Cited: 5
Elham Mohammadi, Seyed Jamal Tabatabaei Rezaei, Keivan Nedaei, et al.
ChemistrySelect (2023) Vol. 8, Iss. 4
Closed Access | Times Cited: 5
Nanomedicines Based on Responsive Nanocarriers for Cancer Therapy
Zhi‐Shan Liu, Jing Wen, Chu‐Yu Huang, et al.
Advanced Therapeutics (2023) Vol. 7, Iss. 2
Closed Access | Times Cited: 4
Zhi‐Shan Liu, Jing Wen, Chu‐Yu Huang, et al.
Advanced Therapeutics (2023) Vol. 7, Iss. 2
Closed Access | Times Cited: 4
Recent developments in synthetic approaches for macromolecular prodrugs
Julien Alex, Christine Weber, Carlos Guerrero‐Sánchez, et al.
Progress in Polymer Science (2024) Vol. 155, pp. 101855-101855
Open Access | Times Cited: 1
Julien Alex, Christine Weber, Carlos Guerrero‐Sánchez, et al.
Progress in Polymer Science (2024) Vol. 155, pp. 101855-101855
Open Access | Times Cited: 1
Improved therapeutic index of the liposomal docetaxel-glutathione prepared by active click loading
XueLi Jin, Qing Zhou, Lei Cao, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 203, pp. 114435-114435
Closed Access | Times Cited: 1
XueLi Jin, Qing Zhou, Lei Cao, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 203, pp. 114435-114435
Closed Access | Times Cited: 1
Hybrid homodimeric prodrug nanoassemblies for low-toxicity and synergistic chemophotodynamic therapy of melanoma
Peirong Xu, Fanchao Meng, Jianqin Wan, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 1
Peirong Xu, Fanchao Meng, Jianqin Wan, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 1
Fabrication, characterization, and in vitro biological evaluation of glycyrrhetinic acid ligand-functionalized proliposomes encapsulated docetaxel for treatment of hepatocellular carcinoma
Lin Yuan, Chuangnan Li, Kaijie Cen, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024), pp. 135802-135802
Closed Access | Times Cited: 1
Lin Yuan, Chuangnan Li, Kaijie Cen, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024), pp. 135802-135802
Closed Access | Times Cited: 1